Teachers Advisors’s Akebia Therapeutics AKBA Stock Holding History

Teachers Advisors’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$8.22M	Buy	1,003,540 +726,490	+262%	+$4.99M	0.01%	1109
2018 Q4	$1.53M	Buy	277,050 +103,315	+59%	+$809K	﹤0.01%	1983
2018 Q3	$1.53M	Buy	173,735 +59,435	+52%	+$532K	﹤0.01%	2106
2018 Q2	$1.14M	Buy	114,300 +33,857	+42%	+$339K	﹤0.01%	2268
2018 Q1	$767K	Hold	80,443	–	–	﹤0.01%	2337
2017 Q4	$1.2M	Buy	80,443 +10,131	+14%	+$168K	﹤0.01%	2153
2017 Q3	$1.38M	Buy	70,312 +1,957	+3%	+$30.1K	﹤0.01%	2056
2017 Q2	$982K	Buy	68,355 +4,551	+7%	+$57.7K	﹤0.01%	2242
2017 Q1	$587K	Hold	63,804	–	–	﹤0.01%	2459
2016 Q4	$664K	Buy	63,804 +2,454	+4%	+$21.1K	﹤0.01%	2387
2016 Q3	$555K	Hold	61,350	–	–	﹤0.01%	2422
2016 Q2	$459K	Buy	61,350 +7,047	+13%	+$61.5K	﹤0.01%	2463
2016 Q1	$489K	Buy	54,303 +19,049	+54%	+$154K	﹤0.01%	2356
2015 Q4	$455K	Hold	35,254	–	–	﹤0.01%	2464
2015 Q3	$341K	Sell	35,254 -2,273	-6%	-$20.9K	﹤0.01%	2605
2015 Q2	$386K	Buy	37,527 +26,465	+239%	+$226K	﹤0.01%	2679
2015 Q1	$123K	Hold	11,062	–	–	﹤0.01%	2990
2014 Q4	$129K	Hold	11,062	–	–	﹤0.01%	3013
2014 Q3	$245K	Hold	11,062	–	–	﹤0.01%	2783
2014 Q2	$307K	Buy	+11,062	New	+$266K	﹤0.01%	2724

Other funds holding AKBA

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Teachers Advisors's AKBA Position: Q1 2019 in Review

Teachers Advisors increased its Akebia Therapeutics (AKBA) stake by 262% in Q1 2019, buying an estimated $4.99M and bringing the position to 1,003,540 shares worth $8.22M. The position accounts for 0.01% of the portfolio, ranked #1109.

Teachers Advisors first reported a position in AKBA in Q2 2014 and has held it in 20 quarters since. 169 funds tracked by Wall St. Rank hold AKBA as of Q1 2019.

Teachers Advisors held 1,003,540 shares of Akebia Therapeutics worth $8.22M as of Q1 2019.
Teachers Advisors bought 726,490 Akebia Therapeutics shares in Q1 2019, an estimated $4.99M.
Akebia Therapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1109 holding.
Teachers Advisors first reported a position in Akebia Therapeutics in Q2 2014 and has held it in 20 quarters since.
169 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.